standardmedia.co.ke2d
Moi Referral hospital and AstraZeneca launch advanced testing to improve lung cancer diagnosis
Bernard Oduor, Associate Director, Government Affairs and Market Access ... an advanced molecular testing platform to enhance lung cancer diagnostics across the country. The collaboration under ...
Cancer Profiling Market Research Report 2024 - Global Forecasts to 2029: Biomarker-Based Tumor Profiling and Point-of-Care Innovations Driving Growth
The "Cancer Profiling Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The ...
Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients
Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...
The Globe and Mail20h
Digital Radiography Market Forecast (2024-2029): Key Players and Competitive Strategies- Arizton
According to Arizton’s latest research report, the digital radiography market is growing at ... such as those with chronic ...
Future Market Insights6d
Global Neuroendocrine Carcinoma Treatment Market to Reach USD 4,305.7 Million by 2034 at a 8.1% of CAGR
The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...
Veracyte initiated with an Outperform at Wolfe on growth, margin potential
As previously reported, Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target The genomic ...
Business Insider2d
Sell Rating on Veracyte: Strong Performance Overshadowed by Limited Immediate Upside
Veracyte (VCYT) Company Description: Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm’s portfolio includes Afirma, Percepta, and Envisia. It ...
pittsburghmagazine.com2d
This Blood Test Can Help to Detect Whether or Not You Have Lung Cancer
“It’s the first clinically validated test on the market,” Zaidi told Pittsburgh Magazine. “And one of the most highly ...